AC Immune S.A.

ACIU | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.65

+$0.02 (+0.76%)

At close: Sep 21, 2026, 4:00 PM ET

$2.65

$0 (+0.19%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.76%

(1D)

Rating

Updated: Aug 24, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $270.21M

1D Range

2.61 2.67

52W Range

2.10 4

Valuation (TTM)

PE -4.89

PB 6.21

EV/EBITDA -3.50

Valuation (NTM)

Forward PE 10.25

Forward PEG 0.03

Price Target $8.33

Cash Flow

FCF Yield -15.7%

SBC Adj. FCF Yield -16.9%

SBC Impact -7.5%

Margins

Gross Margin 100.0%

Operating Margin -252.3%

FCF Margin -199.6%

Growth (CAGR)

Revenue 3Y | 5Y 64.5% | 53.3%

Dil EPS 3Y | 5Y 20.9% | 20.8%

FCF 3Y | 5Y -339.7% | 29.6%

Returns

ROA -28.7%

ROE -99.2%

ROIC -86.6%

Financial Health

Net Cash

CHF75.36M ($93.23M)

Current Ratio 0.93

Interest Coverage -263.40

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

AC Immune S.A. is a biotech firm operating at the clinical stage, dedicated to pioneering, formulating, and advancing therapeutic agents and diagnostic tools. Its core mission is addressing neurodegen...

Sector Healthcare

Industry Biotechnology

Employees 106

IPO Date Sep 22, 2016

Website www.acimmune.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+201.89%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞